Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Dermatology
Rosacea
Rosacea
Rosacea (sometimes referred to as acne rosacea) is a chronic skin disease of unknown aetiology.Features
- typically affects nose, cheeks and forehead
- flushing is often first symptom
- telangiectasia are common
- later develops into persistent erythema with papules and pustules
- rhinophyma
- ocular involvement: blepharitis
- exacerbating factors:
- alcohol
- sunlight
Management
- simple measures
- recommend daily application of a high-factor sunscreen
- camouflage creams may help conceal redness
- predominant erythema/flushing
- topical brimonidine gel may be considered for patients with predominant flushing but limited telangiectasia
- brimonidine is a topical alpha-adrenergic agonist
- this can be used on an 'as required basis' to temporarily reduce redness
- it typically reduces redness within 30 minutes, reaching peak action at 3-6 hours, after which the redness returns to the baseline
- mild-to-moderate papules and/or pustules
- topical ivermectin is first-line
- alternatives include: topical metronidazole or topical azelaic acid
- moderate-to-severe papules and/or pustules
- combination of topical ivermectin + oral doxycycline
Referral should be considered if
- symptoms have not improved with optimal management in primary care
- laser therapy may be appropriate for patients with prominent telangiectasia
- patients with a rhinophyma
+PassMedicine Notes
Rosacea (sometimes referred to as acne rosacea) is a chronic skin disease of unknown aetiology.
Features- typically affects nose, cheeks and forehead
- flushing is often first symptom
- telangiectasia are common
- later develops into persistent erythema with papules and pustules
- rhinophyma
- ocular involvement: blepharitis
- exacerbating factors:
- alcohol
- sunlight
- simple measures
- recommend daily application of a high-factor sunscreen
- camouflage creams may help conceal redness
- predominant erythema/flushing
- topical brimonidine gel may be considered for patients with predominant flushing but limited telangiectasia
- brimonidine is a topical alpha-adrenergic agonist
- this can be used on an 'as required basis' to temporarily reduce redness
- it typically reduces redness within 30 minutes, reaching peak action at 3-6 hours, after which the redness returns to the baseline
- mild-to-moderate papules and/or pustules
- topical ivermectin is first-line
- alternatives include: topical metronidazole or topical azelaic acid
- moderate-to-severe papules and/or pustules
- combination of topical ivermectin + oral doxycycline
- symptoms have not improved with optimal management in primary care
- laser therapy may be appropriate for patients with prominent telangiectasia
- patients with a rhinophyma




